The comparison has a short answer in November 2026. One of the two is being withdrawn from the market, with last shipments to wholesalers late January 2027. The maker states that the decision follows declining use and the arrival of alternatives, and that it is not the result of any safety or quality-related concern[1].
| Saxenda | Wegovy pen | |
|---|---|---|
| Molecule and schedule | Liraglutide, once daily | Semaglutide, once weekly |
| Maintenance dose on the label | 3 mg daily | 2.4 mg weekly |
| What the maker publishes | A list price of $1,349.02, with no pack size stated | A self-pay price of $349 a month |
| Introductory offer | None published | $199 for 2 fills, to December 31, 2026 |
| High-dose option | None | $399 for the 7.2 mg pen |
| Commercial copay card | Not published on the list-price page | As little as $25, capped at $100 saved a month |
| Still being made | Last shipments to wholesalers late January 2027 | Yes |
Why the two prices cannot simply be subtracted
Novo publishes the Saxenda figure as a list price, on a page saying most people whose insurance covers weight-management medicines do not pay it[2]. The page names no pack size.
Without a pack size, the figure cannot be turned into a month. It is what the maker lists, not what a person at a counter pays.
The Wegovy figure is a different kind of number. It is a self-pay price with the pack spelled out: one month is one box of 4 pens[3], which the savings card terms call a 28-day supply[7].
That ladder has three rungs. New self-pay patients pay $199 for the first 2 fills at the two starting doses, then $349, and $399 for the 7.2 mg pen.[3] The introductory rung runs to December 31, 2026[3].
A daily injection against a weekly one
Saxenda is injected subcutaneously once daily, at any time of day, without regard to meals[4]. The recommended adult dose is 3 mg daily, reached by escalating weekly from 0.6 mg[4].
Its pen holds 6 mg/mL in 3 mL and delivers 0.6, 1.2, 1.8, 2.4 or 3 mg[4]. Lower doses on that pen are escalation steps toward 3 mg for adults[4].
The Wegovy pen is once weekly[5]. For anyone counting injections, that is 365 against 52 a year, which is a difference in what a month actually involves rather than in what it costs.
What the head-to-head trial found
The two molecules were compared directly in a 68-week randomized trial at 19 US sites, in 338 adults with overweight or obesity and without diabetes[6].
Participants received once-weekly subcutaneous semaglutide 2.4 mg or once-daily subcutaneous liraglutide 3.0 mg, each against matched placebo, with diet and physical activity[6].
| Group | Mean weight change |
|---|---|
| Semaglutide 2.4 mg weekly (n = 126) | −15.8% |
| Liraglutide 3.0 mg daily (n = 127) | −6.4% |
| Pooled placebo (n = 85) | −1.9% |
More participants reached each weight threshold on semaglutide: 70.9% against 25.6% for 10% or more, 55.6% against 12.0% for 15% or more, and 38.5% against 6.0% for 20% or more[6].
Discontinuation for any reason ran 13.5% on semaglutide and 27.6% on liraglutide, while gastrointestinal adverse events were reported by 84.1% and 82.7%[6].
The trial was funded by the maker of both products, and the comparison between the two active arms was open-label[6]. Both conditions belong beside the figures.
What replaces a discontinued daily pen
The liraglutide price board shows the range across 5 sellers publishing a monthly figure for compounded injections as of October 2026. Those are compounded prices, so the board cannot tell you what a Saxenda pen costs.
The guide to compounded peptides explains how the essentially-a-copy rule affects pharmacy options when a brand changes availability. A price listing alone cannot establish whether a particular pharmacy may fill your prescription.
Our Wegovy insurance guide explains which coverage rules to check before using a cash quote to budget. Coverage can change what you pay even if the list price stays the same.
Our Zepbound and Wegovy cost comparison lines up two weekly brand-name products if you want to compare their cash prices. For a daily alternative, confirm the formulation before comparing any liraglutide quote with the price of a branded pen.
Ask the pharmacy when it expects the last Saxenda shipment to affect your refill. Your prescriber can help you decide whether a different option fits your treatment plan.